Author

M. Hecht

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Bel-Ange· 1 shared A. G. Lopez· 1 shared A. Jaberi· 1 shared A. K. Chemel· 1 shared A. Le· 1 shared A. Lopez· 1 shared A. Pradhananga· 1 shared A. R. Mahoney· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bel-Ange

Author profile →

3 papers

Recent·Most cited

Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications

E. Davis, S. Avniel-Polak, S. Abu-Kamel, I. Antman, T. Saadoun, C. Brim, A. Bel-Ange, K. Atlan, T. Tzur, F. Abu-Akar, O. Wald, U. Izhar, M. Hecht, S. Grozinsky-Glasberg, Y. Drier

This study identifies three regulatory subtypes of lung neuroendocrine tumors through ChIP-seq and RNA-seq, revealing distinct transcription factor signatures and therapeutic vulnerabilities.

bioRxiv · Nov 17, 2023Cancer Biology

The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts

M. Hecht, P. Marrhofer, N. Johnsson, T. Gronemeyer

This study shows that SEPT9 and EPLIN interact to regulate fibroblast adhesion and migration through actin cytoskeleton organization.

bioRxiv · Aug 8, 2022Cell Biology

CpG-creating Mutations are Costly in Many Human Viruses

V. R. Caudill, S. Qin, R. Winstead, J. Kaur, K. Tisthammer, E. G. Pineda, O. Carja, R. M. Eggo., K. Koelle, K. Lythgoe, S. Roy, N. Allen, M. Aviles, B. A. Baker, W. Bauer, , Wint

The paper examines the cost of CpG-creating mutations in various human viruses using existing genomic data and finds they are generally costly.

bioRxiv · Jul 25, 2019Evolutionary Biology